Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
ConditionFirst Episode Psychosis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age15-40
SponsorNorthwell Health
About this trial
Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Enrolled into a CSC program
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
CSC Step-down intervention
Other interventionWeb-based telemedicine and a smartphone app, to decrease disengagement likelihood
Usual Care
Other interventionUsual Care provided by CSC center
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: CSC Step-down interventionOther 1 intervention
Group B: Usual CareOther 1 intervention
Trial outcomes
Primary outcomes
1
Disengagement rate
Rate of disengagement from CSC program
Time frame
Minimum of 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Northwell Health
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov